Influence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatment

References

• Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol 2013;168:934–45.
   PubMed Web of Science ®Google Scholar
• Choi YH, Kurtz A, Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 2011;22:3–17.
   PubMed Web of Science ®Google Scholar
• Friis T, Haack-Sorensen M, Hansen SK, Hansen L, Bindslev L, Kastrup J. Comparison of mesenchymal stromal cells from young healthy donors and patients with severe chronic coronary artery disease. Scand J Clin Lab Invest 2011;71:193–202.
   PubMed Web of Science ®Google Scholar
• Kastrup J. Stem cells therapy for cardiovascular repair in ischemic heart disease: how to predict and secure optimal outcome? EPMA J 2011;2:107–17.
   PubMedGoogle Scholar
• Houtgraaf JH, den Dekker WK, van Dalen BM, Springeling T, de JR, van Geuns RJ, Geleijnse ML, Fernandez-Aviles F, Zijlsta F, Serruys PW, Duckers HJ. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2012;59:539–40.
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294–301.
   PubMed Web of Science ®Google Scholar
• Perin EC, Sanz-Ruiz R, Sanchez PL, Lasso J, Perez-Cano R, Alonso-Farto JC, Perez-David E, Fernandez-Santos ME, Serruys PW, Duckers HJ, Kastrup J, Chamuleau S, Zheng Y, Silva GV, Willerson JT, Fernandez AF. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE Trial. Am Heart J 2014;168:88–95.
   PubMed Web of Science ®Google Scholar
• Qayyum AA, Haack-Sorensen M, Mathiasen AB, Jorgensen E, Ekblond A, Kastrup J. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regen Med 2012;7:421–8.
   PubMed Web of Science ®Google Scholar
• Suzuki E, Fujita D, Takahashi M, Oba S, Nishimatsu H. Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease. World J Cardiol 2015;7:454–65.
   PubMed Web of Science ®Google Scholar
• Mozid AM, Jones D, Arnous S, Saunders N, Wragg A, Martin J, Agrawal S, Mathur A. The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease. Stem Cells Dev 2013;22:216–23.
   PubMed Web of Science ®Google Scholar
• Neef K, Choi YH, Weichel A, Rahmanian PB, Liakopoulos OJ, Stamm C, Choi CY, Jacobshagen C, Wittwer T, Wahlers T. The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness. Cytotherapy 2012;14:670–8.
   PubMed Web of Science ®Google Scholar
• Friis T, Haack-Sorensen M, Mathiasen AB, Ripa RS, Kristoffersen US, Jorgensen E, Hansen L, Bindslev L, Kjaer A, Hesse B, Dickmeiss E, Kastrup J. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina. Scand Cardiovasc J 2011;45:161–8.
   PubMed Web of Science ®Google Scholar
• Haack-Sorensen M, Friis T, Mathiasen AB, Jorgensen E, Hansen L, Dickmeiss E, Ekblond A, Kastrup J. Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up. Cell Transplant 2013;22:521–8.
   PubMed Web of Science ®Google Scholar
• Mathiasen AB, Jorgensen E, Qayyum AA, Haack-Sorensen M, Ekblond A, Kastrup J. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). Am Heart J 2012;164:285–91.
   PubMed Web of Science ®Google Scholar
• Mathiasen AB, Qayyum AA, Jorgensen E, Helqvist S, Fischer-Nielsen A, Kofoed KF, Haack-Sorensen M, Ekblond A, Kastrup J. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J 2015;36:1744–53.
   PubMed Web of Science ®Google Scholar
• Haack-Sorensen M, Bindslev L, Mortensen S, Friis T, Kastrup J. The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use. Cytotherapy 2007;9:328–37.
   PubMed Web of Science ®Google Scholar
• Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 2013;15:641–8.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–17.
   PubMed Web of Science ®Google Scholar
• Kastrup J, Mygind ND, Qayyum AA, Mathiasen AB. Experimental myocardial stem cell therapy for ST-elevation myocardial infarction: rationale and level of evidence. Minerva Cardioangiol 2016;64:322–9.
   PubMed Web of Science ®Google Scholar
• Kastrup J, Mygind ND, Qayyum AA, Mathiasen AB, Haack-Sorensen M, Ekblond A. Mesenchymal stromal cell therapy in ischemic heart disease. Scand Cardiovasc J 2016;50:293–9.
   PubMed Web of Science ®Google Scholar
• Singh A, Singh A, Sen D. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015). Stem Cell Res Ther 2016;7:82.
   PubMed Web of Science ®Google Scholar
• Haack-Sorensen M, Ekblond A, Kastrup J. Cryopreservation and revival of human mesenchymal stromal cells. Methods Mol Biol 2016;1416:357–74.
   PubMedGoogle Scholar
• Haack-Sorensen M, Follin B, Juhl M, Brorsen SK, Sondergaard RH, Kastrup J, Ekblond A. Culture expansion of adipose derived stromal cells. A closed automated Quantum Cell Expansion System compared with manual flask-based culture. J Transl Med 2016;14:319.
   PubMed Web of Science ®Google Scholar
• Sondergaard RH, Follin B, Lund LD, Juhl M, Ekblond A, Kastrup J, Haack-Sorensen M. Senescence and quiescence in adipose-derived stromal cells: effects of human platelet lysate, fetal bovine serum and hypoxia. Cytotherapy 2017;19:95–106.
   PubMed Web of Science ®Google Scholar
• Zhang L, Peng LP, Wu N, Li LP. Development of bone marrow mesenchymal stem cell culture in vitro. Chin Med J (Engl) 2012;125:1650–5.
   PubMed Web of Science ®Google Scholar